nrr podcast logo

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View full description +

LATEST EPISODE

08.27.26

ASRS '26: ArMaDa/GARDian Results and Real-World YAG Complication Incidence

Jay Chhablani, MD; and Jordan Deaner, MD

Can a single molecule treat both GA and Stargardt Disease? And if so, how far along is the research? Jay Chhablani, MD, joins New Retina Radio to share data from ArMaDa and GARDian, which assessed OCU410 (Ocugen) in geographic atrophy and Stargardt disease, respectively.

And Jordan Deaner, MD, sits down to discuss his research on real-world retinal tears and detachments following YAG capsulotomy. What are the actual incidence rates? And what risk factors were identified? Stick with us to find out.

Play Episode

MORE EPISODES

08.20.26

Comparing Ocular AEs in Next-Gen Treatments

Katherine Talcott, MD; Akshay Thomas, MD; and Nita Valikodath, MD, MS

08.18.26

The Story Behind LYTENAVA™: From FDA Approval to Retina Practice

Barry Kuppermann, MD, PhD; and Bob Jahr, CEO of Outlook Therapeutics

08.12.26

The Fellow Eye: Episode 6

Justin C. Muste, MD; David Fell, MD; Monia Reding, MD; and Benjamin Young, MD

08.05.26

ASRS '26: SOL-1 and TRUCKEE at 4.5 Years

Dilsher Dhoot, MD; and Carl Danzig, MD

07.16.26

New Retina Radio Journal Club w/ VBS: Clinical Features and Outcomes of IOFB Removal

Jordan Deaner, MD; Vaidehi Dedania, MD; and Rehan Hussain, MD

07.08.26

Barriers to Care, Patient Education, and Treatment Decisions in Geographic Atrophy

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

07.08.26

Evolving Practice Patterns and Dosing Strategies in Geographic Atrophy

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

07.08.26

Biomarkers, Imaging, and Early Treatment Decisions in Geographic Atrophy

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Show More